Abstract
Botulinum toxins block the release of acetylcholine from neuromuscular junction when injected into the muscles. Acetylcholine upon release from nerve endings activate the muscles. In disease conditions characterized by presence of overactive muscles with involuntary movements (dystonias, tremors, tics) injection of the botulinum toxin into the affected muscles decreases the involuntary movements substantially and improves the patients’ quality of life.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hallett M. Blepharospasm: recent advances. Neurology. 2002;59:1306–12.
Nutt JG, Meunter MD, Aranson A, et al. Epidemiology of focal and generalized dystonia in Rochester Minnesota. Mov Disord. 1988;3:188–94.
Illowsky-Karp B, Alter K. Botulinum treatment of blepharospasm, orofacial/oromandibular dystonia, and hemifacial spas. Semin Neurol. 2016;36:84–91.
Truong D, Comella C, Fernandez HH, et al. Benign Essential Blepharospasm Study Group. Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled phase II trial. Parkinsonism Relat Disord. 2008;14:407–14.
Colosimo C, Bologna M, Lamberti S, et al. A comparative study of primary and secondary hemifacial spasm. Arch Neurol. 2006;63:441–4.
Jankovic J, Adler CH, Charles D. Primary results from cercical dystonia patient registry for observation of onabotulinum toxin A efficacy (CD Probe). J Neurol Sci. 2015;349:84–93.
Bledsoe IO, Comella CL. Botulinum toxin treatment of cervical dystonia. Semin Neurol. 2016;36:47–53.
Brin MF, Comella CL, Jankovic J. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord. 2008;23:1353–60.
Lungo C, Ahmad OF. Update on the use of botulinum toxin therapy for focal and task specific dystonias. Semin Neurol. 2016;36:41–6.
Jindal P, Jankovic J. Botulinum toxin treatment in Parkinson’ disease and atypical Parkinsonian disorders. In: Jabbari B, editor. Botulinum toxin treatment in clinical medicine. A disease- oriented approach. Cham: Springer Publisher; 2018. p. 23–58.
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum toxin in Parkinson disease tremor: a randomized, double-blind, placebo-controlled study with a customized injection approach. Mayo Clin Proc. 2017;92:1359–67.
Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin in simple motor tics. A randomized, double blind, controlled clinical trial. Neurology. 2001;56:605–10.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jabbari, B. (2018). Botulinum Toxin Therapy for Involuntary Movements; Dystonias, Tremor and Tics. In: Botulinum Toxin Treatment . Springer, Cham. https://doi.org/10.1007/978-3-319-99945-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-99945-6_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99944-9
Online ISBN: 978-3-319-99945-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)